We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 203.21%
This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$976M
AUM Growth
+$118M
Cap. Flow
+$533K
Cap. Flow %
0.05%
Top 10 Hldgs %
57.9%
Holding
70
New
10
Increased
18
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$29.1M
2
AXGN icon
Axogen
AXGN
+$20.1M
3
CDNA icon
CareDx
CDNA
+$18.8M
4
ARWR icon
Arrowhead Research
ARWR
+$12.5M
5
HALO icon
Halozyme
HALO
+$12.5M

Top Sells

Rank Stock Value
1
PFNX
Pfenex Inc.
PFNX
+$19.6M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$18.6M
3
UTHR icon
United Therapeutics
UTHR
+$15.5M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
ADVM
Adverum Biotechnologies
ADVM
+$9.81M

Sector Composition

Rank Sector Weight
1 Healthcare 95.42%
2 Communication Services 3.37%
3 Miscellaneous 0.9%
4 Energy 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
1
DELISTED
Immunomedics Inc
IMMU
$134M 13.75%
1,577,880
-90,860
-5% -$4.59M
SPNE
2
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$73M 7.48%
5,105,237
-7,673
-0.2% -$92.9K
CDNA icon
3
CareDx
CDNA
$2.72B
$71.7M 7.35%
1,890,213
+557,275
+42% +$18.8M
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$54.3M 5.56%
4,639,199
+13,997
+0.3% +$186K
KRMD icon
5
KORU Medical Systems
KRMD
$146M
$52.4M 5.37%
7,257,266
-274,884
-4% -$2.44M
HALO icon
6
Halozyme
HALO
$12.1B
$50.1M 5.13%
1,906,789
+448,244
+31% +$12.5M
INSM icon
7
Insmed
INSM
$26.2B
$33M 3.38%
1,025,341
+903
+0.1% +$26K
MODN
8
DELISTED
MODEL N, INC.
MODN
$32.9M 3.37%
931,967
-6,321
-0.7% -$239K
GKOS icon
9
Glaukos
GKOS
$10.1B
$32.2M 3.3%
650,289
-732
-0.1% -$32.2K
OMCL icon
10
Omnicell
OMCL
$1.49B
$31.4M 3.22%
+420,354
New +$29.1M
TNDM icon
11
Tandem Diabetes Care
TNDM
$1.13B
$29.2M 2.99%
257,205
-23,145
-8% -$2.43M
YMAB
12
DELISTED
Y-mAbs Therapeutics
YMAB
$23.3M 2.39%
608,193
+572
+0.1% +$22.8K
NEO icon
13
NeoGenomics
NEO
$2.43B
$22.6M 2.32%
613,102
+420
+0.1% +$15.6K
ATRC icon
14
AtriCure
ATRC
$2.86B
$22.4M 2.29%
561,018
+21,256
+4% +$901K
GMAB icon
15
Genmab
GMAB
$21B
$22.1M 2.27%
603,870
+7,496
+1% +$271K
AXGN icon
16
Axogen
AXGN
$2.42B
$20.1M 2.06%
+1,729,435
New +$20.1M
KRYS icon
17
Krystal Biotech
KRYS
$9.97B
$20M 2.05%
464,663
+484
+0.1% +$21K
ARNA
18
DELISTED
Arena Pharmaceuticals Inc
ARNA
$19.8M 2.03%
265,339
+249
+0.1% +$16.6K
XENT
19
DELISTED
Intersect ENT, Inc
XENT
$19.4M 1.99%
1,188,534
+1,084
+0.1% +$19.6K
TEVA icon
20
Teva Pharmaceuticals
TEVA
$45.7B
$16.8M 1.72%
1,860,025
-224,078
-11% -$2.37M
SIBN icon
21
SI-BONE Inc
SIBN
$831M
$15.9M 1.63%
669,120
-340
-0.1% -$6.75K
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$1.29B
$15.2M 1.56%
184,970
-51,988
-22% -$4.31M
ARWR icon
23
Arrowhead Research
ARWR
$9.98B
$12.5M 1.28%
+290,487
New +$12.5M
QDEL icon
24
QuidelOrtho
QDEL
$729M
$12.4M 1.28%
56,728
+17,380
+44% +$3.88M
OPRX icon
25
OptimizeRx
OPRX
$142M
$12.3M 1.26%
590,000
– –
1
2 3

Similar funds

AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

First Light Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, First Light Asset Management held 70 positions worth $976M, up 14% from $858M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

First Light Asset Management's Q3 2020 filing shows 10 new, 18 increased, 14 reduced and 10 closed positions. Its largest new stake was Omnicell: 420,354 shares worth $31.4M. The largest sale was Pfenex Inc., an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier, followed by Communication Services and Miscellaneous.

  • First Light Asset Management's largest Q3 2020 buy was Omnicell: 420,354 shares worth $31.4M.
  • First Light Asset Management added most to CareDx in Q3 2020, an estimated $18.8M increase.
  • First Light Asset Management's biggest Q3 2020 reduction was Zymeworks, cutting an estimated $9.67M.
  • First Light Asset Management fully exited Pfenex Inc. in Q3 2020, selling an estimated $19.6M.
  • First Light Asset Management's ten largest holdings make up 58% of its $976M portfolio in Q3 2020.
  • First Light Asset Management opened 10 new positions and closed 10 in Q3 2020.
  • First Light Asset Management's portfolio value rose 14% quarter-over-quarter to $976M.

Based on First Light Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.